IDT Australia Limited has received a manufacturing licence extension from the Therapeutic Goods Administration (TGA) for: Medicine manufacture sterile injection /sterile solution of dosage forms of registered therapeutic goods and therapeutic goods for clinical trials (Sterile Licence). This Sterile Licence is an extension to the Company's existing licence to manufacture therapeutic goods which currently covers: Manufacture of active pharmaceutical ingredients; manufacture testing and release for supply of solid unit dosage form tablets and capsules for registered therapeutic goods; and manufacture, testing and release for supply of liquids, powders and granules, inhalation, dry herb and oil products for therapeutic goods for clinical trials (and export of inhalation, dry herb and oil products). The manufacture of sterile dosage form, Injections, solution, is restricted to aseptic primary filling in vials only.2 The license will likely be further extended once IDT has certainty on product content, in alignment with the company achieving other stages in manufacturing capabilities. Once product content is known, likely licence extensions IDT will be seeking in the future would include formulation, modifications to the facility and secondary packaging operations; and would be based on a successful inspection relating to the technical transfer of products into the facility.